These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 12388674

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2.
    Mizoguchi H, Watanabe H, Hayashi T, Sakurada W, Sawai T, Fujimura T, Sakurada T, Sakurada S.
    J Pharmacol Exp Ther; 2006 Apr; 317(1):362-8. PubMed ID: 16394196
    [Abstract] [Full Text] [Related]

  • 7. Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone.
    Sakurada S, Hayashi T, Yuhki M, Fujimura T, Murayama K, Yonezawa A, Sakurada C, Takeshita M, Zadina JE, Kastin AJ, Sakurada T.
    Brain Res; 2000 Oct 20; 881(1):1-8. PubMed ID: 11033087
    [Abstract] [Full Text] [Related]

  • 8. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
    Ohsawa M, Mizoguchi H, Narita M, Chu M, Nagase H, Tseng LF.
    J Pharmacol Exp Ther; 2000 Sep 20; 294(3):1106-11. PubMed ID: 10945866
    [Abstract] [Full Text] [Related]

  • 9. Involvement of mouse μ-opioid receptor splice variants in the spinal antinociception induced by the dermorphin tetrapeptide analog amidino-TAPA.
    Mizoguchi H, Watanabe C, Higashiya T, Takeda S, Moriyama K, Yonezawa A, Sato T, Komatsu T, Sakurada T, Sakurada S.
    Eur J Pharmacol; 2011 Jan 25; 651(1-3):66-72. PubMed ID: 21047509
    [Abstract] [Full Text] [Related]

  • 10. Acute antinociceptive tolerance and asymmetric cross-tolerance between endomorphin-1 and endomorphin-2 given intracerebroventricularly in the mouse.
    Wu HE, Hung KC, Mizoguchi H, Fujimoto JM, Tseng LF.
    J Pharmacol Exp Ther; 2001 Dec 25; 299(3):1120-5. PubMed ID: 11714902
    [Abstract] [Full Text] [Related]

  • 11. Involvement of spinal mu1-opioid receptors on the Tyr-d-Arg-Phe-sarcosine-induced antinociception.
    Mizoguchi H, Nakayama D, Watanabe H, Ito K, Sakurada W, Sawai T, Fujimura T, Sato T, Sakurada T, Sakurada S.
    Eur J Pharmacol; 2006 Jul 01; 540(1-3):67-72. PubMed ID: 16730704
    [Abstract] [Full Text] [Related]

  • 12. The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies.
    Xie H, Woods JH, Traynor JR, Ko MC.
    Anesth Analg; 2008 Jun 01; 106(6):1873-81. PubMed ID: 18499626
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. D-pro(2)-endomorphin-1 and D-pro(2)-endomorphin-2, respectively, attenuate the antinociception induced by endomorphin-1 and endomorphin-2 given intrathecally in the mouse.
    Hung KC, Wu HE, Mizoguchi H, Sakurada S, Okayama T, Fujimura T, Murayama K, Sakurada T, Fujimoto JM, Tseng LF.
    J Pharmacol Exp Ther; 2002 Nov 01; 303(2):874-9. PubMed ID: 12388675
    [Abstract] [Full Text] [Related]

  • 15. Antisense mapping of the MOR-1 opioid receptor clone: modulation of hyperphagia induced by DAMGO.
    Leventhal L, Stevens LB, Rossi GC, Pasternak GW, Bodnar RJ.
    J Pharmacol Exp Ther; 1997 Sep 01; 282(3):1402-7. PubMed ID: 9316853
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of antisense oligodeoxynucleotides directed against g(zalpha) and g(oalpha) on antinociception produced by spinal opioid and alpha(2) adrenergic receptor agonists.
    Karim F, Roerig SC.
    Pain; 2000 Aug 01; 87(2):181-191. PubMed ID: 10924811
    [Abstract] [Full Text] [Related]

  • 17. Differential antagonism of endomorphin-1 and endomorphin-2 supraspinal antinociception by naloxonazine and 3-methylnaltrexone.
    Sakurada S, Hayashi T, Yuhki M, Fujimura T, Murayama K, Yonezawa A, Sakurada C, Takeshita M, Sato T, Zadina JE, Kastin AJ, Sakurada T.
    Peptides; 2002 May 01; 23(5):895-901. PubMed ID: 12084520
    [Abstract] [Full Text] [Related]

  • 18. Identification of endomorphin-1 and endomorphin-2 binding sites in human mu-opioid receptor by antisense oligonucleotide strategy.
    Fichna J, Gach K, Perlikowska R, Poels J, Vanden Broeck J, Szemraj J, Janecka A.
    Chem Biol Drug Des; 2008 Dec 01; 72(6):507-12. PubMed ID: 19090917
    [Abstract] [Full Text] [Related]

  • 19. Endomorphin-1 and endomorphin-2 show differences in their activation of mu opioid receptor-regulated G proteins in supraspinal antinociception in mice.
    Sánchez-Blázquez P, Rodríguez-Díaz M, DeAntonio I, Garzón J.
    J Pharmacol Exp Ther; 1999 Oct 01; 291(1):12-8. PubMed ID: 10490881
    [Abstract] [Full Text] [Related]

  • 20. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
    Sakurada S, Takeda S, Sato T, Hayashi T, Yuki M, Kutsuwa M, Tan-No K, Sakurada C, Kisara K, Sakurada T.
    Eur J Pharmacol; 2000 Apr 28; 395(2):107-12. PubMed ID: 10794815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.